Riboflavin nutritional status and flavoprotein enzymes in streptozotocin-diabetic rats

https://doi.org/10.1016/0304-4165(86)90057-7Get rights and content

Abstract

Riboflavin nutritional status was assessed on the basis of activity coefficients of glutathione reductase in erythrocyte hemolysates of normal and streptozotocin-diabetic rats. Activity coefficient values higher than 1.3 were regarded as evidence of riboflavin deficiency. All diabetic animals were found to be riboflavin-deficient, with activity coefficient values of 1.47–2.11. Treatment of diabetic rats with either insulin or riboflavin returned their activity coefficients to normal. Rats fed a restricted diet had normal activity coefficient values. The erythrocyte glutathione reductase activity was significantly lower in diabetic rats, and the augmentation of enzyme activity in the presence of flavin-adenine dinucleotide (FAD) was 72% compared to 16% in normal rats. Hepatic activities of glutathione reductase and succinate dehydrogenase, both FAD-containing enzymes, were significantly lower in diabetic than in normal rats. Like activity coefficient values, all enzyme activities were normalized after insulin or riboflavin treatments. These data suggest that insulin and riboflavin enhance the synthesis of erythrocyte and hepatic FAD. The results of the present study suggest that experimental diabetes causes riboflavin deficiency, which in turn decreases erythrocyte and hepatic flavoprotein enzyme activities. These changes can be corrected for by either insulin or riboflavin. The pathogenesis of riboflavin deficiency in diabetes mellitus is not clearly understood. The data of the present study provide evidence in addition to the previous findings of an increased prevalence of riboflavin deficiency in genetically diabetic KK mice.

References (18)

  • A.S. Reddi

    Metabolism

    (1978)
  • M.S. Bamji

    Clin. Chim. Acta

    (1969)
  • J.A. Tillotson et al.

    Am. J. Clin. Nutr.

    (1972)
  • Y.P. Lee et al.

    J. Biol. Chem.

    (1965)
  • Y.S. Kim et al.

    J. Nutr.

    (1969)
  • A.S. Reddi et al.

    Diabetes

    (1976)
  • A.S. Reddi
  • D. Glatzle et al.

    Int. J. Vitam. Res.

    (1970)
  • J.A. Tillotson et al.

    J. Nutr.

    (1977)
There are more references available in the full text version of this article.

Cited by (16)

  • The role of PDI as a survival factor in cardiomyocyte ischemia

    2011, Methods in Enzymology
    Citation Excerpt :

    As diabetes has been described to induce a pathologic state called diabetic cardiomyopathy (Hayat et al., 2004; Kannel et al., 1974; Rubler et al., 1972) in which ER stress plays a pivotal role, in this paragraph, we focus on the evaluation of PDI expression and redox state in the diabetic heart. Several pieces of evidence showed that the intracellular level of small molecules as FAD is lower in both diabetic animal models and diabetic patients (Banhegyi et al., 1998, Reddi, 1986) and that the activity of some FAD-containing enzymes, as Ero1, is significantly lower in experimental diabetes (Nardai et al., 2003). In streptozotocin-induced diabetic rats, despite of the oxidative changes of the extracellular space, the redox environment of liver microsomal vesicles was shifted to a more reduced state with an increase of total thiol content and an increase of protein-thiol/disulfide ratio (Nardai et al., 2005).

  • ACP1 genotype, glutathione reductase activity, and riboflavin uptake affect cardiovascular risk in the obese

    2009, Metabolism: Clinical and Experimental
    Citation Excerpt :

    However, riboflavin deficiency has been shown to be highly prevalent among diabetic rats and mice. Eighty-three percent of genetically diabetic KK mice were found to be deficient in riboflavin on a normal diet, showing significantly reduced GR activity [42], whereas 100% of streptozotocin-diabetic rats showed riboflavin deficiency and reduced GR activity [43]. It has been shown that riboflavin supplementation of 1.6 mg/d may significantly reduce levels of homocysteine in homozygote carriers of the 677C3T polymorphism of the MTHFR gene by as much as 40% in those patients with lower riboflavin status at baseline and by 22% overall [44].

  • Diabetic changes in the redox status of the microsomal protein folding machinery

    2005, Biochemical and Biophysical Research Communications
    Citation Excerpt :

    In addition to dehydroascorbic acid, FAD also participates in the redox changes of the ER [50,51]. Earlier data showed that the level of FAD and the activity of FAD-enzymes are both decreased in diabetes [52]. Here, we showed FAD was unable to sufficiently re-oxidize protein thiols in diabetic microsomes despite of the potent oxidation of ER proteins by extramicrosomal FAD [51].

  • Antioxidant systems and erythrocyte life-span in mammals

    1993, Comparative Biochemistry and Physiology -- Part B: Biochemistry and
View all citing articles on Scopus
View full text